Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Depression 2 Breast Neoplasms 2 Neoplasm Metastasis 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Inflammatory Breast Neoplasms 1 Constriction, Pathologic 1 Carcinoma, Hepatocellular 1 Carcinoma, Basal Cell 1 Anxiety Disorders 1

Interventions

daromun 1 Therapeutics 1 Sunscreening Agents 1 Specimen Handling 1 Nivolumab 1 Niacinamide 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 HhAntag691 1 CTLA-4 Antigen 1 Blood Specimen Collection 1 Antineoplastic Protocols 1 Aminolevulinic Acid 1 1-phenyl-3,3-dimethyltriazene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Basal Cell × Therapeutics × 30 days × Clear all

NCT03610022 2026-05-19

OPTIVISMO-1

University Hospital, Bordeaux

Phase 4 Completed

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡